Bloomberg Bayer AG and Johnson & Johnson’s blood-thinning drug Xarelto didn’t prevent clotting in high-risk ...
Read More »Masonry Layout
Musk’s brazen gambit collapsed as investor support withered
Bloomberg Elon Musk’s stunning tweet that he wanted to take Tesla Inc. private and had ...
Read More »China’s tech growth is getting more expensive
China’s consumer growth is a key plank underpinning the investment thesis for many of the ...
Read More »Four Fed hikes isn’t set in stone
Remarks by Fed officials at the symposium in Jackson Hole, Wyoming, confirmed the consensus market ...
Read More »China’s deposit-hungry banks are getting fancy
China’s banks have a deposit problem. For those outside the so-called Big Four lenders, there’s ...
Read More »Switzerland, land of the elegant corporate U-turn
To Switzerland, and a beautifully engineered corporate U-turn. Zurich-based industrial group ABB Ltd. is considering ...
Read More »The contradictions of Trump’s coal fixation
There is a curiously retro aspect to the energy policies of the Trump administration, with ...
Read More »Games Indian banks play deep into injury time
Corporate banking in India is one of those painful-to-watch soccer games stretching goallessly into injury ...
Read More »US leveraged-loan lovefest will end in heartbreak
Moody’s Investors Service published an in-depth look at US leveraged loans. And it seems the ...
Read More »Two-cent fares killing airlines in India market
Bloomberg Global carriers have flocked to India, lured by a domestic travel boom and what’s ...
Read More »